| |
| Reishi-MRL (Ganoderma lucidium) supports the body´s normal cellular immune system.* |
|
While MRL Ltd.´s Ganoderma lucidium powder is not an extract of Ganoderma lucidium, the powder does contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.
 Picture of the Ganoderma lucidium
This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardised production of Ganoderma lucidium. The powder biomass is then sealed in plastic containers. |
|
Our Ganoderma lucidium is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of standardised Ganoderma lucidium product.
The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use. |
|
The fungal biomass Coriolus versicolor that comprises Coriolus-MRL is certified 100% Organic in the United States by Quality Assurance International (Certificate No. 103491-A). In December of 2005, MRL powder gained EU organic certification in accordance with EU Council Regulation (EEC) No. 2092/91 by Quality Assurance International (Certificate No. 105493-A). |
|
|
Each Tablet of Reishi-MRL contains
 |
 |
| Ganoderma lucidium - biomass powder |
500mg |
Other ingredients
 |
| Microcrystalline Cellulose |
| Silica |
| Vegetable Magnesium Sterate |
Reishi-MRL - Enzyme Activity Per 750 mg Tablet
 |
 |
| Protein content |
22.2 mg |
| Reducing sugars |
24.0 mg |
| Protein-bound polysaccharide |
69.5 mg |
| Glucose 2-oxidase activity |
8.2 mU |
| Peroxidase activity |
11.2 mU |
| Laccase activity |
451.5 mU |
| Glucoamylase / beta-glucansase activity |
2.7 U |
| Protease activity |
4.4 mU |
| Superoxide dismutase (SOD) activity |
50.4 mU |
| Cytochrome P-450 |
0.66 nmoles |
| Cytochrome P-450 reductase |
7.05 mU |
| Secondary metabolites (Thrombin inhibitors) |
4.4% | | |
| *This statement has not been evaluated by the Food and Drug Adminstration. The product is not intended to diagnose, treat, cure or prevent any disease. |
| The Virility Store at © Resources for Male Virility, Vitality & Sexual Health Help for Erectile Dysfunction, Impotence, Low Libido, Prostate Gland Enlargement
|
|
|